Ix Therapeutics Overview
- Year Founded
-
2021
- Status
-
Private
- Latest Deal Type
-
Joint Venture
- Financing Rounds
-
1
Ix Therapeutics General Information
Description
Developer of drugs for targeted discovery and early cancer detection intended to offer functional antibodies based on novel and proprietary targets. The company is engaged in therapeutic antibodies against colorectal and lung cancer, helping in individualizing the diagnosis and treatment of cancer and delivering truly personalized medicine to patients.
Contact Information
Website
www.ix-therapeutics.comCorporate Office
- Falkenried 88, Building D
- 20251 Hamburg
- Germany
Corporate Office
- Falkenried 88, Building D
- 20251 Hamburg
- Germany
Ix Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Ix Therapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Ix Therapeutics FAQs
-
When was Ix Therapeutics founded?
Ix Therapeutics was founded in 2021.
-
Where is Ix Therapeutics headquartered?
Ix Therapeutics is headquartered in Hamburg, Germany.
-
What industry is Ix Therapeutics in?
Ix Therapeutics’s primary industry is Drug Discovery.
-
Is Ix Therapeutics a private or public company?
Ix Therapeutics is a Private company.
-
What is Ix Therapeutics’s current revenue?
The current revenue for Ix Therapeutics is .
-
Who are Ix Therapeutics’s investors?
Indivumed Therapeutics and Xlife Sciences have invested in Ix Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process